Can Saccharomyces boulardii treat and eradicate Helicobacter pylori among children instead of bismuth?

Authors : Meryem KEÇELİ BAŞARAN, Nur Şeyma ZENGİN

Pages : 912-916

Doi:10.32322/jhsm.1084384

View : 22 | Download : 12

Publication Date : 2022-05-30

Article Type : Research Paper

Abstract :Aim: The objective of this study is to compare the use of Saccharomyces boulardii insert ignore into journalissuearticles values(S. boulardii); in eradicating Helicobacter pylori insert ignore into journalissuearticles values(H. pylori); in children as an alternative to bismuth, which has a limited scope of application due to its side effects. Material and Method: Included in the study were 220 pediatric patients with symptomatic H. pylori gastritis. The patients were randomized into three treatment groups. Patients who received bismuth or S. boulardii in addition to the standard triple therapy for 14 days were compared with the control group who received only triple therapy. Results: Analysis of the bismuth, S. boulardii, and control groups’ treatment success showed that the H. pylori eradication rate was highest among study participants who received bismuth insert ignore into journalissuearticles values(95.2%);, followed by patients who received S. boulardii insert ignore into journalissuearticles values(92.4%);. The most frequent side effects were observed in the patient group that received bismuth insert ignore into journalissuearticles values(17.5%);. Conclusion: Although bismuth continues to be successful in eradicating H. pylori, alternative treatment protocols are necessary because of its side effects and limited use in pediatric patients. S. boulardii can be administered instead when bismuth can not serve as alternative due to its side effects.
Keywords : Eradication, Helicobacter, side effects, S boulardii, triple therapy